tungstate has been researched along with Diabetes Mellitus, Type 2 in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Burks, DJ; Garcia, A; Gasa, R; Gomis, R; Guinovart, JJ; Kalko, SG; Oliveira, JM; Rebuffat, SA; Zafra, D | 1 |
| Barberà, A; De Tata, V; Fierabracci, V; Masiello, P; Novelli, M; Pocai, A | 1 |
| Barberà, A; Fernàndez-Alvarez, J; Gomis, R; Guinovart, JJ; Truc, A | 1 |
3 other study(ies) available for tungstate and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
Tungstate promotes β-cell survival in Irs2-/- mice.
Topics: Animals; Apoptosis; Cell Survival; Diabetes Mellitus, Type 2; Down-Regulation; Glucose Intolerance; Hypoglycemic Agents; Insulin Receptor Substrate Proteins; Insulin-Secreting Cells; Liver; Male; MAP Kinase Signaling System; Mice; Mice, Inbred C57BL; Mice, Knockout; Phosphorylation; Signal Transduction; Tungsten Compounds | 2014 |
Oral tungstate treatment improves only transiently alteration of glucose metabolism in a new rat model of type 2 diabetes.
Topics: Adipocytes; Administration, Oral; Animals; Blood Glucose; Diabetes Mellitus, Type 2; Drug Administration Schedule; Glucose; Glucose Tolerance Test; Glycogen; In Vitro Techniques; Insulin; Insulin Secretion; Islets of Langerhans; Liver; Male; Muscle, Skeletal; Pancreas; Rats; Rats, Wistar; Time Factors; Tungsten Compounds | 2002 |
Effects of tungstate in neonatally streptozotocin-induced diabetic rats: mechanism leading to normalization of glycaemia.
Topics: Animals; Animals, Newborn; Blood Glucose; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Insulin; Liver Glycogen; Male; Rats; Rats, Wistar; Streptozocin; Tungsten Compounds | 1997 |